

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.39427783 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.16065202 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.93858534 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.89798146 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.81669412 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.81669412 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.37076710 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.32031299 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11315040 |
| 10 | immunoglobulin mediated immune response (GO:0016064) | 4.11135334 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.00200905 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.90566187 |
| 13 | detection of other organism (GO:0098543) | 3.84088216 |
| 14 | detection of bacterium (GO:0016045) | 3.74642307 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 3.61713327 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 3.61713327 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.61713327 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.61713327 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.61713327 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 3.61713327 |
| 21 | response to type I interferon (GO:0034340) | 3.60181382 |
| 22 | cellular response to type I interferon (GO:0071357) | 3.58132313 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.58132313 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.53102995 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.53076232 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 3.51934388 |
| 27 | negative thymic T cell selection (GO:0045060) | 3.34597150 |
| 28 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.33025817 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32055384 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30404520 |
| 31 | B cell mediated immunity (GO:0019724) | 3.29733107 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.29061024 |
| 33 | negative T cell selection (GO:0043383) | 3.28939130 |
| 34 | cellular extravasation (GO:0045123) | 3.28684259 |
| 35 | positive thymic T cell selection (GO:0045059) | 3.26602175 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.25995087 |
| 37 | regulation of antigen processing and presentation (GO:0002577) | 3.21767608 |
| 38 | microglial cell activation (GO:0001774) | 3.19558539 |
| 39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18479090 |
| 40 | T cell migration (GO:0072678) | 3.17726791 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 3.17046575 |
| 42 | response to interleukin-15 (GO:0070672) | 3.15542414 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.15059154 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14034919 |
| 45 | regulation of tolerance induction (GO:0002643) | 3.09807044 |
| 46 | response to peptidoglycan (GO:0032494) | 3.08050215 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.05860613 |
| 48 | positive T cell selection (GO:0043368) | 3.05138985 |
| 49 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.03898225 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.01807387 |
| 51 | regulation of B cell differentiation (GO:0045577) | 3.01748838 |
| 52 | neutrophil activation (GO:0042119) | 3.00975196 |
| 53 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.00628838 |
| 54 | mast cell activation (GO:0045576) | 2.99462914 |
| 55 | detection of external biotic stimulus (GO:0098581) | 2.99176230 |
| 56 | leukocyte aggregation (GO:0070486) | 2.98259138 |
| 57 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.97766511 |
| 58 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.96999706 |
| 59 | cellular response to interleukin-15 (GO:0071350) | 2.94790458 |
| 60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94709157 |
| 61 | regulation of interferon-alpha production (GO:0032647) | 2.94372678 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.92015088 |
| 63 | positive regulation of tolerance induction (GO:0002645) | 2.90285221 |
| 64 | regulation of mast cell activation (GO:0033003) | 2.90255467 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 2.89712047 |
| 66 | interferon-gamma production (GO:0032609) | 2.87009390 |
| 67 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.86317407 |
| 68 | defense response to protozoan (GO:0042832) | 2.85910174 |
| 69 | response to interferon-beta (GO:0035456) | 2.85551852 |
| 70 | dendritic cell chemotaxis (GO:0002407) | 2.83290659 |
| 71 | dendritic cell migration (GO:0036336) | 2.81617258 |
| 72 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.81436327 |
| 73 | regulation of cellular extravasation (GO:0002691) | 2.81299538 |
| 74 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79261461 |
| 75 | granulocyte activation (GO:0036230) | 2.78379015 |
| 76 | T cell selection (GO:0045058) | 2.77895506 |
| 77 | tolerance induction (GO:0002507) | 2.77635438 |
| 78 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76195721 |
| 79 | response to host immune response (GO:0052572) | 2.76195721 |
| 80 | positive regulation of mast cell activation (GO:0033005) | 2.75777391 |
| 81 | activated T cell proliferation (GO:0050798) | 2.75560357 |
| 82 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74773885 |
| 83 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.74250067 |
| 84 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.74250067 |
| 85 | negative regulation of innate immune response (GO:0045824) | 2.72688145 |
| 86 | T-helper 1 type immune response (GO:0042088) | 2.72402444 |
| 87 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.72359208 |
| 88 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.71213286 |
| 89 | respiratory burst (GO:0045730) | 2.70560956 |
| 90 | cytidine deamination (GO:0009972) | 2.69447539 |
| 91 | cytidine metabolic process (GO:0046087) | 2.69447539 |
| 92 | cytidine catabolic process (GO:0006216) | 2.69447539 |
| 93 | leukocyte degranulation (GO:0043299) | 2.67462281 |
| 94 | positive regulation of defense response to virus by host (GO:0002230) | 2.67245522 |
| 95 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.66875875 |
| 96 | response to protozoan (GO:0001562) | 2.65164035 |
| 97 | macrophage activation (GO:0042116) | 2.64163760 |
| 98 | cellular response to exogenous dsRNA (GO:0071360) | 2.63067787 |
| 99 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.62817150 |
| 100 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.62085146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.91540067 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.39326983 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.15184161 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.12308255 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.92181305 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.71899766 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.93309044 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.84688326 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83274636 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.78568085 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61968095 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.51529243 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42362791 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.38943239 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03682641 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99718623 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93618751 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93465198 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 1.92418341 |
| 20 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.87023108 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86624766 |
| 22 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.83402853 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82167059 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81748745 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81305523 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80148686 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77367380 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69618119 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69498113 |
| 30 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69158850 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63631143 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60851726 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60755071 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59694309 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57137821 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.53639238 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50805156 |
| 38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48905549 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.44050582 |
| 40 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37033941 |
| 41 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34950312 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32757861 |
| 43 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32420173 |
| 44 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32028542 |
| 45 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29898536 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29254713 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28414450 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26914539 |
| 49 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23224273 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21077751 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19934905 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19851658 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19310510 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18265252 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18101558 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12669697 |
| 57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09395669 |
| 58 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08954411 |
| 59 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07855506 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06641838 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05272573 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04239431 |
| 63 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02209316 |
| 64 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00891395 |
| 65 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99103850 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 0.97366180 |
| 67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97310894 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97156060 |
| 69 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96816536 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.95587783 |
| 71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94636764 |
| 72 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94161044 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93924392 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92796539 |
| 75 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.91073293 |
| 76 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89997117 |
| 77 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89817050 |
| 78 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88800486 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88694384 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87738687 |
| 81 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86257067 |
| 82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.86092933 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85612493 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85464528 |
| 85 | P300_27268052_Chip-Seq_Bcells_Human | 0.84842177 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84602664 |
| 87 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84415261 |
| 88 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83738808 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81506527 |
| 90 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.78427970 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78000599 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.77899853 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77733533 |
| 94 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77259789 |
| 95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.76845730 |
| 96 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.76526208 |
| 97 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76243740 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.76171681 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75807810 |
| 100 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75059776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.29427390 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.64738285 |
| 3 | MP0005671_abnormal_response_to | 3.39492009 |
| 4 | MP0003436_decreased_susceptibility_to | 3.17237378 |
| 5 | MP0003303_peritoneal_inflammation | 3.15276359 |
| 6 | MP0006082_CNS_inflammation | 3.04706125 |
| 7 | MP0001800_abnormal_humoral_immune | 2.89528992 |
| 8 | MP0009785_altered_susceptibility_to | 2.89320950 |
| 9 | MP0005387_immune_system_phenotype | 2.72311627 |
| 10 | MP0001790_abnormal_immune_system | 2.72311627 |
| 11 | MP0005025_abnormal_response_to | 2.67445034 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.61964944 |
| 13 | MP0000685_abnormal_immune_system | 2.54036912 |
| 14 | MP0002419_abnormal_innate_immunity | 2.51551905 |
| 15 | MP0002723_abnormal_immune_serum | 2.49273079 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.43878483 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.40484220 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.32099727 |
| 19 | MP0001819_abnormal_immune_cell | 2.31309280 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.29512030 |
| 21 | MP0010155_abnormal_intestine_physiology | 2.28196433 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.95487838 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.94125976 |
| 24 | MP0002405_respiratory_system_inflammati | 1.90342329 |
| 25 | MP0009764_decreased_sensitivity_to | 1.89474852 |
| 26 | MP0008004_abnormal_stomach_pH | 1.83997931 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.81719539 |
| 28 | MP0000716_abnormal_immune_system | 1.80422843 |
| 29 | MP0001873_stomach_inflammation | 1.79975088 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.79906372 |
| 31 | MP0003866_abnormal_defecation | 1.79778479 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.78615905 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.77135992 |
| 34 | MP0002398_abnormal_bone_marrow | 1.76739194 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.67234375 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.60084860 |
| 37 | MP0003195_calcinosis | 1.57872312 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.54474295 |
| 39 | MP0005310_abnormal_salivary_gland | 1.52512531 |
| 40 | MP0008469_abnormal_protein_level | 1.51008066 |
| 41 | MP0002722_abnormal_immune_system | 1.46201938 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.43054219 |
| 43 | MP0002429_abnormal_blood_cell | 1.41220835 |
| 44 | MP0005360_urolithiasis | 1.34681562 |
| 45 | MP0004947_skin_inflammation | 1.32869213 |
| 46 | MP0002132_abnormal_respiratory_system | 1.31094666 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.30694347 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.29735220 |
| 49 | MP0001663_abnormal_digestive_system | 1.28785502 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.18976061 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.16172134 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.16172134 |
| 53 | MP0003828_pulmonary_edema | 1.15764024 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.13975912 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.11583243 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.10426046 |
| 57 | MP0003646_muscle_fatigue | 1.09689346 |
| 58 | MP0005365_abnormal_bile_salt | 1.09470120 |
| 59 | MP0003252_abnormal_bile_duct | 1.06210733 |
| 60 | MP0009278_abnormal_bone_marrow | 1.03193313 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.01915891 |
| 62 | MP0005166_decreased_susceptibility_to | 1.00054596 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 0.98879411 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 0.98766510 |
| 65 | MP0002933_joint_inflammation | 0.98181656 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.95888230 |
| 67 | MP0004883_abnormal_blood_vessel | 0.95710824 |
| 68 | MP0002139_abnormal_hepatobiliary_system | 0.92428425 |
| 69 | MP0001501_abnormal_sleep_pattern | 0.89917603 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.89126754 |
| 71 | MP0006054_spinal_hemorrhage | 0.87104590 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.86773993 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.86655758 |
| 74 | MP0003075_altered_response_to | 0.85905245 |
| 75 | MP0005174_abnormal_tail_pigmentation | 0.84241361 |
| 76 | MP0009763_increased_sensitivity_to | 0.82779851 |
| 77 | MP0001853_heart_inflammation | 0.82245085 |
| 78 | MP0004043_abnormal_pH_regulation | 0.81997781 |
| 79 | MP0001851_eye_inflammation | 0.80764842 |
| 80 | MP0002006_tumorigenesis | 0.80426639 |
| 81 | MP0004147_increased_porphyrin_level | 0.80424518 |
| 82 | MP0009840_abnormal_foam_cell | 0.78563277 |
| 83 | MP0002254_reproductive_system_inflammat | 0.77761523 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.77516723 |
| 85 | MP0000249_abnormal_blood_vessel | 0.77336456 |
| 86 | MP0010329_abnormal_lipoprotein_level | 0.76667789 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76572920 |
| 88 | MP0001666_abnormal_nutrient_absorption | 0.76468303 |
| 89 | MP0005164_abnormal_response_to | 0.74761645 |
| 90 | MP0001764_abnormal_homeostasis | 0.72737359 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.71886360 |
| 92 | MP0005381_digestive/alimentary_phenotyp | 0.71026493 |
| 93 | MP0000858_altered_metastatic_potential | 0.70876836 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.70391858 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.68880321 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.68540615 |
| 97 | MP0008872_abnormal_physiological_respon | 0.68485322 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.68172257 |
| 99 | MP0008995_early_reproductive_senescence | 0.67361850 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.67300374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.81669179 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.65684569 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.63559310 |
| 4 | Optic neuritis (HP:0100653) | 4.63559310 |
| 5 | Stomatitis (HP:0010280) | 4.57680558 |
| 6 | Orchitis (HP:0100796) | 4.57006409 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.37319855 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.26190793 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.21917699 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.01545497 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.74687555 |
| 12 | Pustule (HP:0200039) | 3.63460657 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.50702740 |
| 14 | Encephalitis (HP:0002383) | 3.47694318 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.45945640 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.45945640 |
| 17 | T lymphocytopenia (HP:0005403) | 3.43756329 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.43309014 |
| 19 | Meningitis (HP:0001287) | 3.42737243 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 3.34471185 |
| 21 | * Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33473306 |
| 22 | Recurrent skin infections (HP:0001581) | 3.30433058 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.29608620 |
| 24 | * Vasculitis (HP:0002633) | 3.26733537 |
| 25 | Hemoptysis (HP:0002105) | 3.23839216 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.23357462 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19265220 |
| 28 | Obstructive lung disease (HP:0006536) | 3.19265220 |
| 29 | * Abnormality of T cell number (HP:0011839) | 3.16317874 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.10436336 |
| 31 | * Abnormality of T cells (HP:0002843) | 3.02519552 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 2.94134034 |
| 33 | Chronic diarrhea (HP:0002028) | 2.93361151 |
| 34 | Prolonged bleeding time (HP:0003010) | 2.91245320 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.89698400 |
| 36 | Recurrent viral infections (HP:0004429) | 2.88688892 |
| 37 | Chest pain (HP:0100749) | 2.61076950 |
| 38 | Agammaglobulinemia (HP:0004432) | 2.59305493 |
| 39 | Pulmonary embolism (HP:0002204) | 2.59189610 |
| 40 | * Leukocytosis (HP:0001974) | 2.56544750 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.56082385 |
| 42 | Epistaxis (HP:0000421) | 2.55589225 |
| 43 | Gangrene (HP:0100758) | 2.53960188 |
| 44 | Anorexia (HP:0002039) | 2.51053012 |
| 45 | * Abnormality of T cell physiology (HP:0011840) | 2.49253193 |
| 46 | Hematochezia (HP:0002573) | 2.49122216 |
| 47 | Arterial thrombosis (HP:0004420) | 2.48426618 |
| 48 | * Stomach cancer (HP:0012126) | 2.47593516 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.46776357 |
| 50 | Increased IgE level (HP:0003212) | 2.45949365 |
| 51 | Gingival bleeding (HP:0000225) | 2.45669532 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.43657835 |
| 53 | Recurrent bronchitis (HP:0002837) | 2.37893868 |
| 54 | Abnormality of the pleura (HP:0002103) | 2.37164771 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.34583156 |
| 56 | Gingivitis (HP:0000230) | 2.31764588 |
| 57 | Decreased circulating renin level (HP:0003351) | 2.31037574 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30073364 |
| 59 | Joint swelling (HP:0001386) | 2.29369756 |
| 60 | IgG deficiency (HP:0004315) | 2.26906012 |
| 61 | Chronic otitis media (HP:0000389) | 2.22385678 |
| 62 | * Urticaria (HP:0001025) | 2.17545983 |
| 63 | IgM deficiency (HP:0002850) | 2.16508839 |
| 64 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15071811 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.12164738 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.07943011 |
| 67 | Lymphopenia (HP:0001888) | 2.07255161 |
| 68 | Alveolar cell carcinoma (HP:0006519) | 2.03947658 |
| 69 | Abnormality of iron homeostasis (HP:0011031) | 2.03541403 |
| 70 | * Autoimmune thrombocytopenia (HP:0001973) | 2.02852396 |
| 71 | Episodic fever (HP:0001954) | 2.02842119 |
| 72 | Colitis (HP:0002583) | 2.02636838 |
| 73 | * Eosinophilia (HP:0001880) | 2.01579719 |
| 74 | Polyneuropathy (HP:0001271) | 2.00760007 |
| 75 | * Granulocytopenia (HP:0001913) | 2.00303006 |
| 76 | Petechiae (HP:0000967) | 1.99844849 |
| 77 | * Autoimmune hemolytic anemia (HP:0001890) | 1.99362798 |
| 78 | Skin rash (HP:0000988) | 1.98065766 |
| 79 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.97069917 |
| 80 | Amyloidosis (HP:0011034) | 1.92597964 |
| 81 | Osteomyelitis (HP:0002754) | 1.91426601 |
| 82 | Severe combined immunodeficiency (HP:0004430) | 1.90961947 |
| 83 | * Abnormality of eosinophils (HP:0001879) | 1.90838877 |
| 84 | Malnutrition (HP:0004395) | 1.89740390 |
| 85 | Vertigo (HP:0002321) | 1.89514044 |
| 86 | Congenital stationary night blindness (HP:0007642) | 1.89114683 |
| 87 | Increased serum ferritin (HP:0003281) | 1.88919502 |
| 88 | Amaurosis fugax (HP:0100576) | 1.87960764 |
| 89 | Thrombophlebitis (HP:0004418) | 1.87480176 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 1.86366475 |
| 91 | Hypochromic microcytic anemia (HP:0004840) | 1.85664060 |
| 92 | Acute hepatic failure (HP:0006554) | 1.84792083 |
| 93 | Microcytic anemia (HP:0001935) | 1.83841449 |
| 94 | Prostate neoplasm (HP:0100787) | 1.81070382 |
| 95 | Keratitis (HP:0000491) | 1.80470179 |
| 96 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80384133 |
| 97 | Abnormality of the renal cortex (HP:0011035) | 1.80016983 |
| 98 | Attenuation of retinal blood vessels (HP:0007843) | 1.79504619 |
| 99 | Thyroiditis (HP:0100646) | 1.79330461 |
| 100 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.79098826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.09425550 |
| 2 | TXK | 4.00400713 |
| 3 | MAP4K1 | 3.98319576 |
| 4 | FRK | 3.11186592 |
| 5 | RIPK4 | 2.98696748 |
| 6 | BLK | 2.69875479 |
| 7 | ACVR1B | 2.57134472 |
| 8 | TYK2 | 2.44543810 |
| 9 | IRAK4 | 2.29230875 |
| 10 | MAP3K14 | 2.25480624 |
| 11 | FES | 2.25336214 |
| 12 | IKBKE | 2.09498929 |
| 13 | ITK | 2.07753579 |
| 14 | CSK | 2.02825144 |
| 15 | TEC | 2.01672925 |
| 16 | SYK | 2.00961851 |
| 17 | JAK3 | 2.00768738 |
| 18 | BTK | 1.93091542 |
| 19 | GRK6 | 1.91311917 |
| 20 | ZAP70 | 1.88148789 |
| 21 | KIT | 1.81994210 |
| 22 | ADRBK2 | 1.60684644 |
| 23 | TBK1 | 1.57215028 |
| 24 | IKBKB | 1.56593812 |
| 25 | TNK2 | 1.51615227 |
| 26 | MAP3K13 | 1.47907201 |
| 27 | LYN | 1.44664806 |
| 28 | JAK1 | 1.43881801 |
| 29 | ERN1 | 1.40553693 |
| 30 | LCK | 1.38542264 |
| 31 | HCK | 1.38228731 |
| 32 | MAP2K3 | 1.36873015 |
| 33 | TIE1 | 1.26805790 |
| 34 | MATK | 1.22076175 |
| 35 | PIK3CG | 1.18215244 |
| 36 | FGR | 1.17856729 |
| 37 | JAK2 | 1.13914063 |
| 38 | BMPR2 | 1.13619306 |
| 39 | IRAK1 | 1.13127233 |
| 40 | CSF1R | 1.09570619 |
| 41 | TLK1 | 1.09040403 |
| 42 | CAMKK2 | 1.08034052 |
| 43 | BMPR1B | 1.07539662 |
| 44 | PRKCQ | 0.97145731 |
| 45 | NLK | 0.94676444 |
| 46 | GRK7 | 0.89465106 |
| 47 | FGFR3 | 0.86346321 |
| 48 | PIM1 | 0.83423569 |
| 49 | TGFBR2 | 0.83192136 |
| 50 | GRK1 | 0.80597544 |
| 51 | MAP3K11 | 0.74882691 |
| 52 | DAPK2 | 0.74712546 |
| 53 | PINK1 | 0.74449344 |
| 54 | MAP2K6 | 0.74308766 |
| 55 | PRPF4B | 0.74112025 |
| 56 | MARK3 | 0.73945049 |
| 57 | ZAK | 0.73753473 |
| 58 | MAP3K3 | 0.71001109 |
| 59 | CAMKK1 | 0.69982604 |
| 60 | PDK1 | 0.69173376 |
| 61 | PIK3CA | 0.68701683 |
| 62 | NUAK1 | 0.67889493 |
| 63 | INSRR | 0.67088643 |
| 64 | KDR | 0.66869543 |
| 65 | MAP3K7 | 0.65973137 |
| 66 | PRKAA2 | 0.65154548 |
| 67 | PTK2B | 0.61301748 |
| 68 | EPHA3 | 0.61007114 |
| 69 | TAOK1 | 0.58404653 |
| 70 | MAP3K1 | 0.54153360 |
| 71 | TESK2 | 0.54045102 |
| 72 | OXSR1 | 0.53769115 |
| 73 | EPHB1 | 0.51139322 |
| 74 | CHUK | 0.50038798 |
| 75 | STK10 | 0.49185034 |
| 76 | MAPK7 | 0.48673687 |
| 77 | ADRBK1 | 0.48339373 |
| 78 | TRPM7 | 0.48184254 |
| 79 | PASK | 0.46101130 |
| 80 | MAPK11 | 0.46012067 |
| 81 | HIPK2 | 0.45262126 |
| 82 | MAP2K2 | 0.44485910 |
| 83 | CDC42BPA | 0.42495523 |
| 84 | FYN | 0.41797766 |
| 85 | PDPK1 | 0.41192890 |
| 86 | PRKG2 | 0.40407544 |
| 87 | IGF1R | 0.39561474 |
| 88 | FGFR4 | 0.39326675 |
| 89 | YES1 | 0.38905828 |
| 90 | MAPK12 | 0.38459129 |
| 91 | ABL1 | 0.33015300 |
| 92 | EGFR | 0.30169611 |
| 93 | SIK3 | 0.29882210 |
| 94 | SGK2 | 0.26710142 |
| 95 | TGFBR1 | 0.26670515 |
| 96 | STK11 | 0.25380428 |
| 97 | MAPK3 | 0.24214759 |
| 98 | MAP3K5 | 0.24121156 |
| 99 | MAP3K2 | 0.23971531 |
| 100 | PRKCD | 0.22677896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.58188045 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.46612197 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.26228107 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.11642616 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.06855764 |
| 6 | Asthma_Homo sapiens_hsa05310 | 3.03658622 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.65305314 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63484684 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.59835772 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.54040933 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07287313 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03900712 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94479941 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.89975756 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.89463815 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82753025 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.62530716 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60157928 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.58422503 |
| 20 | * Tuberculosis_Homo sapiens_hsa05152 | 1.56793665 |
| 21 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54389152 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53741103 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.51963419 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.47366799 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45016171 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.38963192 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.38355081 |
| 28 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33731684 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.33304814 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28983986 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28349774 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.28302490 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27941032 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23538524 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.21042698 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15730697 |
| 37 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.15103352 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.13341599 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12346933 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06015109 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04703760 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.02695649 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99774117 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99190678 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98321205 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97812410 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 0.97620296 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95902671 |
| 49 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94184893 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92891408 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89001354 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83760647 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82760827 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.81801421 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79913619 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78050345 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75716614 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.71084060 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.65910835 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65749515 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63850023 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.62031787 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61502637 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61134439 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59364467 |
| 66 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59331144 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58024253 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56494221 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56485457 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55257705 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55243381 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52482557 |
| 73 | * Hepatitis B_Homo sapiens_hsa05161 | 0.50384188 |
| 74 | * Apoptosis_Homo sapiens_hsa04210 | 0.46685525 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44557950 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44531160 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42183244 |
| 78 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40884525 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.39633191 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39599027 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39577400 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38823673 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37593085 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36394508 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36245492 |
| 86 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36036900 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.35512731 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33937861 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.33444677 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32976907 |
| 91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.32877164 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.32868551 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31846600 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27460101 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26742665 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25960555 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25853648 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.23428037 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22869226 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.21591693 |

